Scientists hint at novel therapies to treat cancer

DC
Published Dec 29, 2013, 11:55 am IST
Updated Mar 19, 2019, 3:21 am IST
Nanotechnology-based therapies to target genetic markers for treating cancer.

Nellore“Novel therapies are at work in finding carcinomas and innovating curative treatment for cancer,” said Prof. Jamboor K. Vishwanatha, dean, professor of molecular biology, University of North Texas Health Science Centre, USA.

He was delivering his plenary talk during the international symposium on “Environmental pollution, nutrition & genetics” and a special symposium on “Cancer biology and therapeutics” held here under the auspices of Vikrama Simhapuri University on Saturday.

 

He explained about developing nanotechnology-based therapies to target genetic markers for treating critical breast cancer patients. The second plenary talk was delivered by Dr Balwantsinh Chauhan and Dr. Prashant Sakharkar, from Roosevelt University, USA.

They dwelt on understanding risk factors and their contribution in the development of breast cancer stressing that it is useful for targeting interventions and providing appropriate therapy to breast cancer patients.

They gave the overview of breast cancer risk prediction models and its applications in clinical practice to mitigate the challenges of prevention and treatment of breast cancer in developing world.

 

Dr. Susobhan Das, Intas Pharmaceuticals Ltd. Gujarat, described antibody based technology platforms in treating various diseases and presented some interesting results for developing novel antibody platforms and exploring their development as therapeutic agents.

His presentation also enlightened on the importance of developing next generation bio-therapeutics through novel platform based technologies.

Dr. Riyaz M. Basha, Institute for Cancer Research, University of North Texas Health Science Centre, Texas, USA presented the results on the investigational new agents for treating pancreatic cancer patients. He also demonstrated the strategies for enhancing therapeutic efficacy of standard therapeutic options in cancer patients.

 

The other plenary talks are rendered by Prof. Sucharita from Sri Padmavathi Mahila University, Tirupati, on the cancer causing carcinomas and the holding back agents at work to stall the progression of the disease through antioxidant treatment.

Dr. Kasturi, department of biotechnology, Acharya Nagarjuna University, spoke on biotechnological approaches to cancer cure and the novel strategies at work in the treatment of cancer.

The second day of the symposium was focused on “Cancer biology and therapeutics” as planned earlier. There were oral presentations and poster presentations along with the competitive renderings for the Young Scientist Awards.

 

...
Location: Andhra Pradesh




ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
-->